Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Maytansinoid-conjugated humanised monoclonal antibody against CD56

EU orphan designation number: EU/3/10/746   
Active ingredient: Maytansinoid-conjugated humanised monoclonal antibody against CD56
Indication: Treatment of Merkel cell carcinoma
Sponsor: ImmunoGen Europe Limited
c/o Reeves LLC, 24 Chiswell Street, Third Floor, London EC1Y 4YX, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
11/06/2010 Centralised Orphan - Designation EMEA/OD/155/09 (2010)3839 of 09/06/2010
25/07/2012 Other procedure EMA/OD/155/09